CPhi Preview 2013: Pfizer

Article

2013 CPhI Exhibitor Preview

Company: Pfizer CentreSource

Description: Pfizer CentreSource (PCS) integrates Pfizer’s world-class analytical, regulatory, technical support and production expertise to provide greater flexibility and help third-party customers work in accelerated timeframes.  Key manufacturing assets include world-class bioprocessing facilities in the United States and Europe, as well as high-containment capabilities in Europe. PCS also offers specialty dosage form manufacturing and an array of active pharmaceutical ingredients and  fine chemical intermediates.

Website: www.pfizercentresource.com

Booth Number: 30D54

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content